The promise of digitizing smell has long been a frontier for deeptech, more often associated with culinary or consumer applications. ILias AI, a two-year-old startup from Seoul, is taking a different path. Its first public product is a security scanner, a device it calls a digital sniffer dog, designed to detect narcotics on passengers and baggage at airport gates using olfactory AI [CES.tech, 2026]. For a company with minimal public presence, it is a stark and specific opening gambit, placing patient and public safety at the center of its bet rather than sensory enhancement.
A Hardware Wedge in a Nascent Field
ILias AI is building a hardware-plus-software platform, aiming to provide on-demand digital olfactory data services and AI-based solutions [Ilias AI, 2024]. The field is crowded with ambitious names like Aryballe, Aromyx, and Osmo, but ILias's initial focus appears to be a narrow, high-stakes wedge. The digital sniffer dog system is claimed to be the world's first product that can detect drug possession based on smell, capturing air from a person or their luggage for analysis [CES.tech, 2026]. This positions the company not in the lab or the kitchen, but in the regulated, high-consequence environment of airport security,a domain where accuracy and reliability are non-negotiable and subject to rigorous validation.
The Seoul-Based Bet and Its Backers
Founded in 2022 by Bumsuk Ko and Jung Gook Seo, ILias AI has operated with notable discretion. Public records show it has participated in the Tesoro AI + Semiconductor Accelerator Program and secured funding from Tesoro VC, with an estimated total of around $670,000 across two undisclosed rounds [Next Unicorn, 2026] [Platum, 2026]. The company's leadership and technical team backgrounds are not detailed in available sources, a common characteristic for very early-stage deeptech ventures where intellectual property and stealth development often precede public profiles. The backing from a sector-specific accelerator suggests a belief in the underlying sensor and AI semiconductor technology required to make digital olfaction work reliably.
| Founder | Role | Public Background Note |
|---|---|---|
| Bumsuk Ko | Co-Founder | Co-authored a paper on internet security and data protection in 2001 [UKEssays.com, 2026]. |
| Jung Gook Seo | Co-Founder & CBO | Listed as Founder on company profiles [TechCrunch]. |
Navigating a Field of Technical and Commercial Risks
The ambition is clear, but the path is fraught with challenges familiar to any hardware-AI hybrid. The competitive landscape is both broad and deep, with well-funded players pursuing varied applications.
- Technical validation. The core claim of detecting specific narcotics via airborne odor signatures in a busy airport environment requires extraordinary sensitivity and specificity. Without peer-reviewed data or published performance metrics against controlled substances, the technology remains an ambitious assertion.
- Regulatory gatekeeping. Deploying a novel detection device in an airport security lane would require approvals from national aviation and security authorities, a process that is typically measured in years, not months, and demands exhaustive clinical-grade testing.
- Commercial focus. While the digital sniffer dog is a vivid flagship, the company's stated offering includes a wider suite like an olfactory smart tunnel and portable scanners [Bloomberg Markets, 2024]. Success may depend on whether ILias AI can dominate its initial niche or must spread resources across multiple, unproven applications.
The standard of care for narcotics detection at airports today is a multi-layered process. It relies on a combination of intelligence, passenger profiling, physical searches, and the use of trace detection equipment like ion mobility spectrometers that analyze chemical swabs. Canine units remain a highly effective, mobile biological sensor. Any new technology must prove it can match or exceed this combined system's accuracy and speed while integrating seamlessly into high-throughput security workflows. For ILias AI, the patient population, in this context, is the traveling public, and the intended outcome is a safer journey free from the threats of drug smuggling and trafficking.
Sources
- [CES.tech, 2026] ILias AI digital sniffer dog product description | https://www.ces.tech
- [Ilias AI, 2024] Company product and service description | https://www.iliasai.com/
- [Next Unicorn, 2026] Funding information for ILias AI | https://www.nextunicorn.kr
- [Platum, 2026] Funding information for ILias AI | https://platum.kr
- [UKEssays.com, 2026] Reference to Bumsuk Ko's co-authored paper | https://www.ukessays.com/essays/information-technology/privacy-and-data-protection-information-technology-essay.php
- [TechCrunch] ILias AI Startup Battlefield directory entry | https://techcrunch.com/startup-battlefield/company/ilias-ai/
- [Bloomberg Markets, 2024] ILias AI company profile and product listing | https://www.bloomberg.com/profile/company/2455132D:KS
- [CB Insights, 2024] Ilias AI company overview | https://www.cbinsights.com/company/ilias-ai